Aemetis Inc. logo

Aemetis Inc. (AMTX)

Market Closed
24 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
3. 27
-0.03
-0.91%
$
165M Market Cap
- P/E Ratio
0% Div Yield
560,429 Volume
-1.09 Eps
$ 3.3
Previous Close
Day Range
3.25 3.38
Year Range
1.22 4.73
Want to track AMTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 6 days
Aemetis India Plant Receives $31 million of Biodiesel Orders from OMCs for Delivery in Next Three Months

Aemetis India Plant Receives $31 million of Biodiesel Orders from OMCs for Delivery in Next Three Months

Listen: CUPERTINO, Calif., April 21, 2025 – PRISM MediaWire – Aemetis, Inc.

Prismmediawire | 3 months ago
Aemetis Biogas Monthly RNG Production Increased by 55% in March

Aemetis Biogas Monthly RNG Production Increased by 55% in March

Sales of LCFS credits and D3 RINs completed at the end of Q1 CUPERTINO, Calif., April 08, 2025 – PRISM MediaWire – Aemetis, Inc.

Prismmediawire | 3 months ago
Aemetis, Inc. (AMTX) Q4 2024 Earnings Call Transcript

Aemetis, Inc. (AMTX) Q4 2024 Earnings Call Transcript

Aemetis, Inc. (NASDAQ:AMTX ) Q4 2024 Earnings Conference Call March 13, 2025 2:00 PM ET Company Participants Todd Waltz - EVP, CFO Eric McAfee - Founder, Chairman and CEO Andy Foster - President of Aemetis Advanced Fuels Conference Call Participants Jordan Levy - Truist Securities Sameer Joshi - HC Wainwright Derrick Whitfield - Texas Capital Matthew Blair - Tudor, Pickering, Holt & Co Dave Storms - Stonegate Ed Woo - Ascendiant Capital Operator Welcome to the Aemetis Fourth Quarter and Year End 2024 Earnings Review Conference Call. At this time, all participants are in a listen-only mode.

Seekingalpha | 4 months ago
Aemetis: I Have Serious Concerns

Aemetis: I Have Serious Concerns

Aemetis faces severe financial distress, with their SEC Filing raising "substantial doubts" about their ability to "continue as a going concern". Most notably, they face impending debt maturities as well as a lack of profitability with almost non-existent gross margins. Their equity issuances are highly dilutive due to a weak share price, and thus they are not a viable strategy to relieve their financial distress.

Seekingalpha | 7 months ago
Aemetis, Inc. (AMTX) Q3 2024 Earnings Call Transcript

Aemetis, Inc. (AMTX) Q3 2024 Earnings Call Transcript

Aemetis, Inc. (NASDAQ:AMTX ) Q3 2024 Earnings Call November 12, 2024 2:00 PM ET Company Participants Todd Waltz - Executive Vice President and Chief Financial Officer Eric McAfee - Founder, Chairman and Chief Executive Officer Andy Foster - President, North America Conference Call Participants Manav Gupta - UBS Henry Stephen - Truist Amit Dayal - H.C. Wainwright Matthew Blair - TPH Dave Storms - Stonegate Ed Woo - Ascendiant Capital Operator Good day, ladies and gentlemen, and welcome to the Aemetis Third Quarter 2024 Earnings Review Conference Call.

Seekingalpha | 8 months ago
Aemetis (AMTX) Reports Q3 Loss, Tops Revenue Estimates

Aemetis (AMTX) Reports Q3 Loss, Tops Revenue Estimates

Aemetis (AMTX) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.59 per share a year ago.

Zacks | 8 months ago
Aemetis, Inc. (AMTX) Q2 2024 Earnings Call Transcript

Aemetis, Inc. (AMTX) Q2 2024 Earnings Call Transcript

Aemetis, Inc. (NASDAQ:AMTX ) Q2 2024 Earnings Conference Call August 1, 2024 2:00 PM ET Company Participants Todd Waltz - Executive Vice President & Chief Financial Officer Eric McAfee - Founder, Chairman & Chief Executive Officer Andy Foster - President, North America Conference Call Participants Manav Gupta - UBS Jordan Levy - Truist Matthew Blair - TPH Amit Dayal - H.C. Wainwright Dave Storms - Stonegate Ed Woo - Ascendiant Capital Operator Greetings and welcome to the Aemetis Second Quarter 2024 Earnings Review Conference Call.

Seekingalpha | 11 months ago
Aemetis (AMTX) Reports Q2 Loss, Lags Revenue Estimates

Aemetis (AMTX) Reports Q2 Loss, Lags Revenue Estimates

Aemetis (AMTX) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.68 per share a year ago.

Zacks | 11 months ago
7 Cheap Stocks Under $10 With 10X Potential: July 2024

7 Cheap Stocks Under $10 With 10X Potential: July 2024

Many cheap stocks under $10 are cheap for a good reason. Cash-burning biotechs, sketchy shell companies and overhyped fads with more sizzle than substance.

Investorplace | 11 months ago